Zivo Bioscience, Inc. (ZIVO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$1.44M2011: -$1.29M2012: -$1.77M2013: -$2.99M2014: -$2.74M2015: -$2.30M2016: -$2.54M2017: -$4.24M2018: -$5.01M2019: -$3.71M2020: -$2.59M2021: -$6.80M2022: -$7.10M2023: -$5.80M2024: -$4.31M-$4.31M
2010Operating Cash Flow (USD)2024
Fiscal YearOperating Cash FlowChange YoY
2024-$4.31M+25.6%
2023-$5.80M+18.3%
2022-$7.10M-4.4%
2021-$6.80M-162.8%
2020-$2.59M+30.2%
2019-$3.71M+26.0%
2018-$5.01M-18.0%
2017-$4.24M-66.8%
2016-$2.54M-10.7%
2015-$2.30M+16.1%
2014-$2.74M+8.4%
2013-$2.99M-68.4%
2012-$1.77M-37.0%
2011-$1.29M+10.1%
2010-$1.44M